Maziar Mike Doustdar

Maziar Mike Doustdar is the President and CEO of Novo Nordisk, a global healthcare company focused on defeating serious chronic diseases such as diabetes, obesity, and cardiovascular conditions. He leads the company’s mission to innovate and expand access to treatments that improve patient outcomes. Doustdar frequently shares updates on Novo Nordisk’s strategic initiatives, including acquisitions, partnerships, and advancements in medical research. He actively participates in industry events, engages with policymakers, and emphasizes the importance of collaboration in addressing global health challenges. His content highlights Novo Nordisk’s commitment to patient-centric innovation and its role in shaping the future of healthcare.